カテゴリー： Market Monitor Global, 世界, 医療/バイオ

分子残留疾患検出装置のグローバル市場展望 2023年-2029年：腫瘍情報アッセイ、腫瘍診断アッセイ

◆英語タイトル：Molecular Residual Disease Detection Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC12399）

◆商品コード：MMG23DC12399
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月（※2025年版があります。お問い合わせください。）
◆ページ数：68
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

分子残留疾患検出装置（Molecular Residual Disease Detection、MRD検出装置）は、特にがん治療において病状の監視や治療効果の評価に重要な役割を果たす技術です。この技術は、治療後に体内に残存する微量ながん細胞（残留疾患）を特定・定量するためのもので、治療の成否や再発のリスクを評価するために使用されます。MRD検出は現在、血液中の腫瘍DNAや腫瘍細胞、あるいはそれに関連するバイオマーカーを測定することで行われています。

MRD検出装置の定義は、主に微量のがん細胞やがん特異的な遺伝子変異を検出することに特化した装置や技術を指します。これらの装置は、患者の血液や骨髄、その他の体液から腫瘍由来のバイオマーカーを高感度で検出することができ、その結果は患者の治療方針の決定に影響を与える可能性があります。

MRD検出装置の主な特徴は、まずその高感度な検出能力です。通常の画像診断や細胞診に比べ、数個のがん細胞やがん特異的DNA配列を検出できるため、早期の再発を発見できる可能性があります。また、MRD検出は非侵襲的な手法であり、患者にとって負担が少ないという特徴があります。さらに、治療の過程で定期的に測定を行うことで、患者の治療反応をリアルタイムで把握することができ、早期に治療方針を見直すことが可能です。

MRD検出装置の種類には、いくつかの技術が存在します。最も一般的なものは、循環腫瘍DNA（ctDNA）を対象とする液体生検技術です。この技術は、血液中の腫瘍由来のDNAを抽出し、特定の遺伝子変異をPCR（ポリメラーゼ連鎖反応）や次世代シーケンシング（NGS）などの手法を用いて解析します。また、フローサイトメトリーを利用した免疫表現型分析もMRDの検出に使用されることがあります。この手法は、がん細胞の表面に特異的に発現するマーカーを利用して、細胞を識別・定量するものです。

MRD検出装置の用途は幅広く、特に血液腫瘍、例えば急性リンパ性白血病（ALL）や慢性骨髄性白血病（CML）、そしてホジキンリンパ腫や非ホジキンリンパ腫などのリンパ球関連のがんにおいて重要な役割を果たしています。これらの疾患では、治療が成功しても、病気の再発リスクが高いため、MRD検出による再発の早期発見が鍵となります。また、固形腫瘍においても、ctDNA解析は治療反応を評価する手助けとなりつつあります。

MRD検出は、単に再発の早期発見にとどまらず、患者の治療方針の決定にも大きな影響を与えます。たとえば、MRD陽性であれば追加の治療を検討することが推奨される一方、MRD陰性であれば治療を中止または減量することが可能になる場合があります。このように、MRD検出は個別化医療の一環として、患者一人ひとりに最適な治療を提供するために不可欠な技術となっています。

MRD検出に関連する技術としては、液体生検や次世代シーケンシング、デジタルPCR、マルチプレックスPCRなどが挙げられます。液体生検は、従来の組織生検に代わる新しい方法として注目されており、非侵襲的かつ短時間で結果が得られるため、多くの研究や臨床応用が進んでいます。次世代シーケンシングは、膨大な遺伝情報を同時に解析できるため、個々の患者のがんに特異的な変異を詳細に調査することが可能です。デジタルPCRは、非常に少量のDNAを高感度で定量する技術であり、MRD検出の精度向上に寄与しています。マルチプレックスPCRは、複数の標的遺伝子を同時に解析することで、効率的かつ迅速にMRDを評価する手法です。

今後の展望としては、MRD検出の精度をさらに向上させるための研究が進められており、人工知能（AI）や機械学習との融合も期待されています。これにより、大量のデータを解析し、MRD検出のアルゴリズムを最適化することで、より精度の高い診断が可能になるかもしれません。また、MRD検出技術の普及が進むことで、より多くの患者に対して個別化医療が実現し、治療成績が向上することが期待されています。

総じて、分子残留疾患検出装置は、がん治療の分野において重要な技術であり、今後の研究や技術革新が楽しみな分野でもあります。患者の生活の質を向上させるために、MRD検出技術が果たす役割はますます重要になると考えられます。

当調査レポートは次の情報を含め、世界の分子残留疾患検出装置市場規模と予測を収録しています。・世界の分子残留疾患検出装置市場：売上、2018年-2023年、2024年-2029年
・世界の分子残留疾患検出装置市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の分子残留疾患検出装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「腫瘍情報アッセイ」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

分子残留疾患検出装置のグローバル主要企業は、Adaptive、 Guardant Health、 Invitae、 Cergentis B.V、 LexentBio、 Natera、 BGI、 Zhiben Medical、 Burning Rock Medicine、 Huidu Medical、 Zhenhe Technology、 ExactSciencesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、分子残留疾患検出装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の分子残留疾患検出装置市場：タイプ別、2018年-2023年、2024年-2029年
世界の分子残留疾患検出装置市場：タイプ別市場シェア、2022年
・腫瘍情報アッセイ、腫瘍診断アッセイ

世界の分子残留疾患検出装置市場：用途別、2018年-2023年、2024年-2029年
世界の分子残留疾患検出装置市場：用途別市場シェア、2022年
・予後予測、術後補助療法決定、術後再発サーベイランス、その他

世界の分子残留疾患検出装置市場：地域・国別、2018年-2023年、2024年-2029年
世界の分子残留疾患検出装置市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における分子残留疾患検出装置のグローバル売上、2018年-2023年
・主要企業における分子残留疾患検出装置のグローバル売上シェア、2022年
・主要企業における分子残留疾患検出装置のグローバル販売量、2018年-2023年
・主要企業における分子残留疾患検出装置のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Adaptive、 Guardant Health、 Invitae、 Cergentis B.V、 LexentBio、 Natera、 BGI、 Zhiben Medical、 Burning Rock Medicine、 Huidu Medical、 Zhenhe Technology、 ExactSciences

*************************************************************

・調査・分析レポートの概要
分子残留疾患検出装置市場の定義
市場セグメント
世界の分子残留疾患検出装置市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の分子残留疾患検出装置市場規模
世界の分子残留疾患検出装置市場規模：2022年 VS 2029年
世界の分子残留疾患検出装置市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの分子残留疾患検出装置の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の分子残留疾患検出装置製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：腫瘍情報アッセイ、腫瘍診断アッセイ
分子残留疾患検出装置のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：予後予測、術後補助療法決定、術後再発サーベイランス、その他
分子残留疾患検出装置の用途別グローバル売上・予測

・地域別市場分析
地域別分子残留疾患検出装置市場規模 2022年と2029年
地域別分子残留疾患検出装置売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Adaptive、 Guardant Health、 Invitae、 Cergentis B.V、 LexentBio、 Natera、 BGI、 Zhiben Medical、 Burning Rock Medicine、 Huidu Medical、 Zhenhe Technology、 ExactSciences
...

This research report provides a comprehensive analysis of the Molecular Residual Disease Detection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Molecular Residual Disease Detection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Molecular Residual Disease Detection, challenges faced by the industry, and potential opportunities for market players.
The global Molecular Residual Disease Detection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Molecular Residual Disease Detection market presents opportunities for various stakeholders, including Prognosis, Adjuvant Treatment Decision-Making. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Molecular Residual Disease Detection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Molecular Residual Disease Detection market was valued at US$ 4414.1 million in 2022 and is projected to reach US$ 12700 million by 2029, at a CAGR of 16.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Molecular Residual Disease Detection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Molecular Residual Disease Detection market.
Market Overview: The report provides a comprehensive overview of the Molecular Residual Disease Detection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Tumor-informed Assays, Tumor-agnostic Assays), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Molecular Residual Disease Detection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Molecular Residual Disease Detection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Molecular Residual Disease Detection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Molecular Residual Disease Detection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Molecular Residual Disease Detection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Molecular Residual Disease Detection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Molecular Residual Disease Detection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Molecular Residual Disease Detection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Molecular Residual Disease Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Tumor-informed Assays
Tumor-agnostic Assays
Market segment by Application
Prognosis
Adjuvant Treatment Decision-Making
Surveillance for Postoperative Recurrence
Other
Global Molecular Residual Disease Detection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Adaptive
Guardant Health
Invitae
Cergentis B.V
LexentBio
Natera
BGI
Zhiben Medical
Burning Rock Medicine
Huidu Medical
Zhenhe Technology
ExactSciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Residual Disease Detection, market overview.
Chapter 2: Global Molecular Residual Disease Detection market size in revenue.
Chapter 3: Detailed analysis of Molecular Residual Disease Detection company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Residual Disease Detection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Molecular Residual Disease Detection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Residual Disease Detection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Residual Disease Detection Overall Market Size
2.1 Global Molecular Residual Disease Detection Market Size: 2022 VS 2029
2.2 Global Molecular Residual Disease Detection Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Residual Disease Detection Players in Global Market
3.2 Top Global Molecular Residual Disease Detection Companies Ranked by Revenue
3.3 Global Molecular Residual Disease Detection Revenue by Companies
3.4 Top 3 and Top 5 Molecular Residual Disease Detection Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Residual Disease Detection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Residual Disease Detection Players in Global Market
3.6.1 List of Global Tier 1 Molecular Residual Disease Detection Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Residual Disease Detection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Molecular Residual Disease Detection Market Size Markets, 2022 & 2029
4.1.2 Tumor-informed Assays
4.1.3 Tumor-agnostic Assays
4.2 By Type – Global Molecular Residual Disease Detection Revenue & Forecasts
4.2.1 By Type – Global Molecular Residual Disease Detection Revenue, 2018-2023
4.2.2 By Type – Global Molecular Residual Disease Detection Revenue, 2024-2029
4.2.3 By Type – Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Molecular Residual Disease Detection Market Size, 2022 & 2029
5.1.2 Prognosis
5.1.3 Adjuvant Treatment Decision-Making
5.1.4 Surveillance for Postoperative Recurrence
5.1.5 Other
5.2 By Application – Global Molecular Residual Disease Detection Revenue & Forecasts
5.2.1 By Application – Global Molecular Residual Disease Detection Revenue, 2018-2023
5.2.2 By Application – Global Molecular Residual Disease Detection Revenue, 2024-2029
5.2.3 By Application – Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Molecular Residual Disease Detection Market Size, 2022 & 2029
6.2 By Region – Global Molecular Residual Disease Detection Revenue & Forecasts
6.2.1 By Region – Global Molecular Residual Disease Detection Revenue, 2018-2023
6.2.2 By Region – Global Molecular Residual Disease Detection Revenue, 2024-2029
6.2.3 By Region – Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Molecular Residual Disease Detection Revenue, 2018-2029
6.3.2 US Molecular Residual Disease Detection Market Size, 2018-2029
6.3.3 Canada Molecular Residual Disease Detection Market Size, 2018-2029
6.3.4 Mexico Molecular Residual Disease Detection Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Molecular Residual Disease Detection Revenue, 2018-2029
6.4.2 Germany Molecular Residual Disease Detection Market Size, 2018-2029
6.4.3 France Molecular Residual Disease Detection Market Size, 2018-2029
6.4.4 U.K. Molecular Residual Disease Detection Market Size, 2018-2029
6.4.5 Italy Molecular Residual Disease Detection Market Size, 2018-2029
6.4.6 Russia Molecular Residual Disease Detection Market Size, 2018-2029
6.4.7 Nordic Countries Molecular Residual Disease Detection Market Size, 2018-2029
6.4.8 Benelux Molecular Residual Disease Detection Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Molecular Residual Disease Detection Revenue, 2018-2029
6.5.2 China Molecular Residual Disease Detection Market Size, 2018-2029
6.5.3 Japan Molecular Residual Disease Detection Market Size, 2018-2029
6.5.4 South Korea Molecular Residual Disease Detection Market Size, 2018-2029
6.5.5 Southeast Asia Molecular Residual Disease Detection Market Size, 2018-2029
6.5.6 India Molecular Residual Disease Detection Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Molecular Residual Disease Detection Revenue, 2018-2029
6.6.2 Brazil Molecular Residual Disease Detection Market Size, 2018-2029
6.6.3 Argentina Molecular Residual Disease Detection Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Molecular Residual Disease Detection Revenue, 2018-2029
6.7.2 Turkey Molecular Residual Disease Detection Market Size, 2018-2029
6.7.3 Israel Molecular Residual Disease Detection Market Size, 2018-2029
6.7.4 Saudi Arabia Molecular Residual Disease Detection Market Size, 2018-2029
6.7.5 UAE Molecular Residual Disease Detection Market Size, 2018-2029
7 Molecular Residual Disease Detection Companies Profiles
7.1 Adaptive
7.1.1 Adaptive Company Summary
7.1.2 Adaptive Business Overview
7.1.3 Adaptive Molecular Residual Disease Detection Major Product Offerings
7.1.4 Adaptive Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.1.5 Adaptive Key News & Latest Developments
7.2 Guardant Health
7.2.1 Guardant Health Company Summary
7.2.2 Guardant Health Business Overview
7.2.3 Guardant Health Molecular Residual Disease Detection Major Product Offerings
7.2.4 Guardant Health Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.2.5 Guardant Health Key News & Latest Developments
7.3 Invitae
7.3.1 Invitae Company Summary
7.3.2 Invitae Business Overview
7.3.3 Invitae Molecular Residual Disease Detection Major Product Offerings
7.3.4 Invitae Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.3.5 Invitae Key News & Latest Developments
7.4 Cergentis B.V
7.4.1 Cergentis B.V Company Summary
7.4.2 Cergentis B.V Business Overview
7.4.3 Cergentis B.V Molecular Residual Disease Detection Major Product Offerings
7.4.4 Cergentis B.V Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.4.5 Cergentis B.V Key News & Latest Developments
7.5 LexentBio
7.5.1 LexentBio Company Summary
7.5.2 LexentBio Business Overview
7.5.3 LexentBio Molecular Residual Disease Detection Major Product Offerings
7.5.4 LexentBio Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.5.5 LexentBio Key News & Latest Developments
7.6 Natera
7.6.1 Natera Company Summary
7.6.2 Natera Business Overview
7.6.3 Natera Molecular Residual Disease Detection Major Product Offerings
7.6.4 Natera Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.6.5 Natera Key News & Latest Developments
7.7 BGI
7.7.1 BGI Company Summary
7.7.2 BGI Business Overview
7.7.3 BGI Molecular Residual Disease Detection Major Product Offerings
7.7.4 BGI Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.7.5 BGI Key News & Latest Developments
7.8 Zhiben Medical
7.8.1 Zhiben Medical Company Summary
7.8.2 Zhiben Medical Business Overview
7.8.3 Zhiben Medical Molecular Residual Disease Detection Major Product Offerings
7.8.4 Zhiben Medical Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.8.5 Zhiben Medical Key News & Latest Developments
7.9 Burning Rock Medicine
7.9.1 Burning Rock Medicine Company Summary
7.9.2 Burning Rock Medicine Business Overview
7.9.3 Burning Rock Medicine Molecular Residual Disease Detection Major Product Offerings
7.9.4 Burning Rock Medicine Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.9.5 Burning Rock Medicine Key News & Latest Developments
7.10 Huidu Medical
7.10.1 Huidu Medical Company Summary
7.10.2 Huidu Medical Business Overview
7.10.3 Huidu Medical Molecular Residual Disease Detection Major Product Offerings
7.10.4 Huidu Medical Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.10.5 Huidu Medical Key News & Latest Developments
7.11 Zhenhe Technology
7.11.1 Zhenhe Technology Company Summary
7.11.2 Zhenhe Technology Business Overview
7.11.3 Zhenhe Technology Molecular Residual Disease Detection Major Product Offerings
7.11.4 Zhenhe Technology Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.11.5 Zhenhe Technology Key News & Latest Developments
7.12 ExactSciences
7.12.1 ExactSciences Company Summary
7.12.2 ExactSciences Business Overview
7.12.3 ExactSciences Molecular Residual Disease Detection Major Product Offerings
7.12.4 ExactSciences Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.12.5 ExactSciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Molecular Residual Disease Detection Market Opportunities & Trends in Global Market
Table 2. Molecular Residual Disease Detection Market Drivers in Global Market
Table 3. Molecular Residual Disease Detection Market Restraints in Global Market
Table 4. Key Players of Molecular Residual Disease Detection in Global Market
Table 5. Top Molecular Residual Disease Detection Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Molecular Residual Disease Detection Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Molecular Residual Disease Detection Revenue Share by Companies, 2018-2023
Table 8. Global Companies Molecular Residual Disease Detection Product Type
Table 9. List of Global Tier 1 Molecular Residual Disease Detection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Residual Disease Detection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Molecular Residual Disease Detection Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Molecular Residual Disease Detection Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Molecular Residual Disease Detection Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Molecular Residual Disease Detection Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Molecular Residual Disease Detection Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Molecular Residual Disease Detection Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Molecular Residual Disease Detection Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Molecular Residual Disease Detection Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Molecular Residual Disease Detection Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Molecular Residual Disease Detection Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Molecular Residual Disease Detection Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Molecular Residual Disease Detection Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Molecular Residual Disease Detection Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Molecular Residual Disease Detection Revenue, (US$, Mn), 2024-2029
Table 30. Adaptive Company Summary
Table 31. Adaptive Molecular Residual Disease Detection Product Offerings
Table 32. Adaptive Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 33. Adaptive Key News & Latest Developments
Table 34. Guardant Health Company Summary
Table 35. Guardant Health Molecular Residual Disease Detection Product Offerings
Table 36. Guardant Health Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 37. Guardant Health Key News & Latest Developments
Table 38. Invitae Company Summary
Table 39. Invitae Molecular Residual Disease Detection Product Offerings
Table 40. Invitae Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 41. Invitae Key News & Latest Developments
Table 42. Cergentis B.V Company Summary
Table 43. Cergentis B.V Molecular Residual Disease Detection Product Offerings
Table 44. Cergentis B.V Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 45. Cergentis B.V Key News & Latest Developments
Table 46. LexentBio Company Summary
Table 47. LexentBio Molecular Residual Disease Detection Product Offerings
Table 48. LexentBio Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 49. LexentBio Key News & Latest Developments
Table 50. Natera Company Summary
Table 51. Natera Molecular Residual Disease Detection Product Offerings
Table 52. Natera Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 53. Natera Key News & Latest Developments
Table 54. BGI Company Summary
Table 55. BGI Molecular Residual Disease Detection Product Offerings
Table 56. BGI Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 57. BGI Key News & Latest Developments
Table 58. Zhiben Medical Company Summary
Table 59. Zhiben Medical Molecular Residual Disease Detection Product Offerings
Table 60. Zhiben Medical Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 61. Zhiben Medical Key News & Latest Developments
Table 62. Burning Rock Medicine Company Summary
Table 63. Burning Rock Medicine Molecular Residual Disease Detection Product Offerings
Table 64. Burning Rock Medicine Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 65. Burning Rock Medicine Key News & Latest Developments
Table 66. Huidu Medical Company Summary
Table 67. Huidu Medical Molecular Residual Disease Detection Product Offerings
Table 68. Huidu Medical Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 69. Huidu Medical Key News & Latest Developments
Table 70. Zhenhe Technology Company Summary
Table 71. Zhenhe Technology Molecular Residual Disease Detection Product Offerings
Table 72. Zhenhe Technology Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 73. Zhenhe Technology Key News & Latest Developments
Table 74. ExactSciences Company Summary
Table 75. ExactSciences Molecular Residual Disease Detection Product Offerings
Table 76. ExactSciences Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 77. ExactSciences Key News & Latest Developments
List of Figures
Figure 1. Molecular Residual Disease Detection Segment by Type in 2022
Figure 2. Molecular Residual Disease Detection Segment by Application in 2022
Figure 3. Global Molecular Residual Disease Detection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Molecular Residual Disease Detection Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Molecular Residual Disease Detection Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Residual Disease Detection Revenue in 2022
Figure 8. By Type - Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 9. By Application - Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 10. By Type - Global Molecular Residual Disease Detection Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 12. By Application - Global Molecular Residual Disease Detection Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 14. By Region - Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 15. By Country - North America Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 16. US Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 20. Germany Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 21. France Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 28. China Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 32. India Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 34. Brazil Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 37. Turkey Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 41. Adaptive Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Guardant Health Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Invitae Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cergentis B.V Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. LexentBio Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Natera Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BGI Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Zhiben Medical Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Burning Rock Medicine Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Huidu Medical Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Zhenhe Technology Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. ExactSciences Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 分子残留疾患検出装置のグローバル市場展望 2023年-2029年：腫瘍情報アッセイ、腫瘍診断アッセイ(Molecular Residual Disease Detection Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

分子残留疾患検出装置のグローバル市場展望 2023年-2029年：腫瘍情報アッセイ、腫瘍診断アッセイ

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp